2310079F23Rik Inhibitors

Chemical inhibitors classified as potential modulators of Trmt44 are not directly targeting the enzyme but are influencing the methylation pathways within the cell. These compounds typically act by modifying the availability or functionality of S-adenosylmethionine (SAM), the universal methyl donor for methylation reactions, or by altering the activity of other methyltransferases whose function may be intertwined with that of Trmt44. Some compounds, like adenosine periodate and periodate-oxidized adenosine, achieve this by oxidizing adenosine moieties, potentially disrupting the methylation cycle. Others, such as sinefungin and neplanocin A, are analogs that directly inhibit enzymes involved in the methylation cycle, thereby having an indirect impact on Trmt44 activity.

Notably, several of these chemicals, including BIX-01294, RG108, and decitabine, are primarily known to target DNA methylation. However, changes in DNA methylation patterns can have downstream effects on RNA processes, including the methylation of tRNA, which is the primary function of Trmt44. By influencing the global methylation landscape, these compounds could, therefore, indirectly modulate the activity of RNA methyltransferases.